← Evidence map

ArticleFrontiers in bioengineering and biotechnology2025

A preclinical study of a novel dual-modality contrast agent in rodent models.

Xuelai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40182986